Sci-Tech Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.

Press releases published on September 22, 2026

Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Caseware Named as Finalist in Three Categories at the 2026 A.I. Awards
Elevar Therapeutics Receives FDA Conditional Acceptance of LYRFIGTU as Brand Name for Lirafugratinib
Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
Funnel enters a new era as multifamily’s first front-office-only AI platform
New Phocas State of Sales in Distribution 2026 Report reveals AI use is growing but key sales metrics go untracked
What Defines a Leading Utilization Review Company in 2026
Kunfupay sees 46% revenue uplift in Peru after integrating one-click checkout enabled by EBANX
IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review
エクアティブ、ブランド向けにチャットGPT広告を提供する広告パートナーに
Equativ 以廣告合作夥伴身份將 ChatGPT 廣告帶給各大品牌
Equativ Brings ChatGPT Ads to Brands as Advertising Partner
Equativ מביאה ChatGPT Ads למותגים כשותפת פרסום
Equativ, ChatGPT Ads 기술 파트너로 합류하며 브랜드 광고 지원
Equativ Membawakan Iklan ChatGPT kepada Jenama sebagai Rakan Pengiklanan
Equativ 成为 ChatGPT 广告合作伙伴,助力品牌触达受众
Equativ bringt ChatGPT Ads als Werbepartner zu Marken
Equativ porta l'advertising di ChatGPT ai brand come partner ufficiale
A Equativ traz o ChatGPT Ads para as marcas como parceira de publicidade

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.